Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-05
2011-07-05
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252120, C514S277000, C514S439000, C514S520000, C514S526000, C544S158000, C544S358000, C544S360000, C546S192000, C546S265000, C549S029000, C558S437000, C558S438000, C558S439000, C558S440000
Reexamination Certificate
active
07973037
ABSTRACT:
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
REFERENCES:
patent: 7375134 (2008-05-01), Bayly et al.
patent: 2005/0014941 (2005-01-01), Black et al.
patent: 2005/0182096 (2005-08-01), Link et al.
patent: 2006/0111440 (2006-05-01), Gauthier et al.
patent: WO 00/49007 (2000-08-01), None
patent: WO 00/55126 (2000-09-01), None
patent: 00/55125 (2000-12-01), None
patent: 01/19796 (2001-03-01), None
Alessandro Volonterio, et al. “Synthesis of Partially Modified Retro and Retroinverso—[NHCH(CF3)]-Peptides,” Organic Letters 2000, vol. 2, No. 13, 1827-1830.
Alessandro Volonterio, et al. “Solution/solid-phase synthesis of partially modified retro-[NHCH(CF3)]-peptidyl hydroxamates,” Tetrahedron Letters 42 (2001), 3141-3144.
Alessandro Volonterio, et al. “Solid-phase synthesis of partially-modified retro and retro-inverso—[NHCH(CF3)]-peptides,” Tetrahedron Letters 41 (2000) 6517-6521.
Ishii, et al. “Asymmetric Addition Reactions of Grignard Reagents to Chiral Fluoral Hemiacetal: Asymmetric Synthesis of 1-Substituted-2,2,2,-Trifluoroethylamines,” Synlett, Dec. 1997, 1381-1382.
Ishii, et al. “Stereospecific Reduction with Retention of Chiral Fluoral-derived 1,3-Oxazolidines with LiA1H4: Asymmetric Synthesis of 1-Substituted 2,2,2-Trifluoroethylamines,” Chem. Letters 1998, 119-120.
Baskaran Chitra
Bayly Christopher I.
Black Cameron
Gauthier Jacques Yves
Green Michael J.
AxyS Pharmaceuticals, Inc.
Beeler Nicole M.
Merck Canada Inc.
Muthard David A.
Sackey Ebenezer
LandOfFree
Cathepsin cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cathepsin cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cathepsin cysteine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712943